Sales Nexus CRM

Creative Biolabs Launches Antibody Tools for Neuroscience Research Targeting Key Disease Mechanisms

By FisherVista

TL;DR

Creative Biolabs' new antibody products for GRID2, TH, and ACTN3 research give scientists a competitive edge in developing targeted neurological treatments and muscle disorder therapies.

Creative Biolabs provides specific antibodies that enable researchers to systematically study synaptic proteins, neurotransmitter synthesis, and muscle genetics through established methods like Western blot and immunohistochemistry.

These research tools advance understanding of neurological diseases and muscle disorders, potentially leading to better treatments that improve quality of life for patients worldwide.

Discover how Creative Biolabs' antibody products help researchers map synaptic function and muscle genetics, revealing fascinating connections between molecular biology and human movement.

Found this article helpful?

Share it with your network and spread the knowledge!

Creative Biolabs Launches Antibody Tools for Neuroscience Research Targeting Key Disease Mechanisms

The development of specialized antibody tools by Creative Biolabs represents a significant advancement for neuroscience research, particularly as the global burden of neurological disorders continues to escalate. These tools target three critical proteins involved in distinct aspects of nervous system function, offering researchers precise instruments to investigate disease mechanisms and potential therapeutic interventions.

Research has demonstrated that mutations in the GRID2 gene can lead to cerebellar ataxia and learning deficits, showing that GRID2 plays a dominant role in motor coordination and synaptic transmission. In neurological disease models, abnormal GRID2 expression reflects not only molecular mechanisms of neural circuit imbalance but also provides a rationale for the potential of targeted interventions. Creative Biolabs has produced a range of anti-GRID2 antibody products, including Rabbit Anti-GRID2 Recombinant Antibody and Mouse Anti-GRID2 Recombinant Antibody, available to the scientific community. These products are applicable in ELISA, flow cytometry, Western blotting, and immunohistochemistry.

A neuroscientist at Creative Biolabs remarked that in the field of investigating synaptic function, GRID2 has emerged as a key point for understanding both cerebellar development and mechanism learning. The antibody tool sets aim to assist researchers in generating clearer molecular maps within cell and animal model systems. The availability of these highly specific products allows researchers to accurately study spatial characteristics and dynamic regulation of synaptic proteins, which is crucial for understanding conditions like cerebellar ataxia.

In neurotransmitter metabolism research, tyrosine hydroxylase (TH) plays a pivotal role as the rate-limiting enzyme in catecholamine synthesis, catalyzing the conversion of L-tyrosine to L-DOPA, which subsequently produces dopamine, norepinephrine, and epinephrine. Especially in Parkinson's disease research, changes in TH levels would reflect the functional state of dopaminergic neurons. TH is therefore an important marker for drug discovery and disease diagnosis. The scientist stated that as a rate-limiting enzyme in catecholamine synthesis, TH research is critical to understanding underlying mechanisms related to Parkinson's disease but also to the development of new neuroprotective strategies.

Creative Biolabs offers the Mouse Anti-Tyrosine Hydroxylase Recombinant Antibody (AV1), optimized for Western blot and immunohistochemistry applications, helping researchers sensitively capture molecular changes along neurotransmitter synthesis pathways. This tool is particularly valuable for Parkinson's disease research, where understanding dopamine synthesis pathways is essential for developing effective treatments.

Beyond neurotransmitters and synaptic function, genetic regulation in the motor system has attracted increasing attention. The ACTN3 gene encodes α-actinin-3, a critical protein for maintaining the structural integrity and explosive power of fast-twitch muscle fibers. In research practice, Creative Biolabs provides a number of ACTN3-related products, including Mouse Anti-ACTN3 Recombinant Antibody and Rabbit Anti-ACTN3 Recombinant Antibody with high specificity and cross-species applications. These tools support studies in sports genetics, muscle disorders, and personalized training research, addressing the growing interest in genetic factors affecting physical performance and muscle health.

The development of these antibody tools comes at a critical time when neurodegenerative diseases, movement disorders, and psychiatric disorders represent an increasing global health challenge. The nervous system's complexity requires research that combines molecular biology, structural biology, and clinical medicine, making precise research tools essential for advancing our understanding of these conditions. These antibody products provide researchers with the means to investigate molecular mechanisms with greater accuracy, potentially accelerating the discovery of new treatment approaches and diagnostic methods for various neurological and muscular disorders.

Curated from 24-7 Press Release

blockchain registration record for this content
FisherVista

FisherVista

@fishervista